Search Within

Michael John Mauro

Formats
  1. Meeting Abstract (188)
  2. Journal Article (67)
  3. Review (8)
  4. Correspondence (4)
  5. Research Letter (3)
  6. Book Section (2)
  7. Editorial (2)
  8. Guidelines (2)
Groups
  1. Adult Leukemia (276)
  2. Center for Hematologic Malignancies (276)
  3. Department of Medicine (276)
  4. Hematologic Malignancies, Division of (276)
  5. Biostatistics Service (10)
  6. Epidemiology and Biostatistics (10)

More Groups

People
  1. Raajit Rampal (12)
  2. Ellin Berman (8)
  3. Eytan Stein (8)
  4. Martin Tallman (7)
  5. Amber King (6)
  6. Andriy Derkach (6)

More People

Years
  1. 2025 (7)
  2. 2024 (17)
  3. 2023 (26)
  4. 2022 (33)
  5. 2021 (21)
  6. 2020 (26)

More Years

Publications
  1. Blood (97)
  2. Clinical Lymphoma, Myeloma and Leukemia (44)
  3. Journal of Clinical Oncology (22)
  4. Haematologica (21)
  5. Leukemia (12)
  6. American Journal of Hematology (8)

More Publications

Publishers
  1. American Society of Hematology (101)
  2. Elsevier Inc. (47)
  3. American Society of Clinical Oncology (22)
  4. Ferrata Storti Foundation (21)
  5. Nature Publishing Group (13)
  6. John Wiley & Sons (8)

More Publishers

Results (276)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Kinetics of BCR-ABL after TKI interruption during pregnancy in CML: A multinational retrospective analysis
    Meeting Abstract

    Lee, J. O.; Kim, D. W.; Abruzzese, E.; Apperley, J.; Caldwell, L.; Mauro, M. J.
    Blood (2018)

    Fulltext@MSK | Save
  • Patients' perspectives on the definition of cure in chronic myeloid Leukemia: A US based survey
    Meeting Abstract

    George, G.; Atallah, E. L.; Mauro, M. J.; Goldberg, S. L.; Baim, A.; Guhl, J.; Hinman, A.; Cortes, J. E.; Deininger, M. W.; Druker, B. J.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Clinical development of asciminib (ABL001) in chronic myeloid leukemia (CML): A randomized phase 3 study vs. bosutinib
    Meeting Abstract

    Mauro, M. J.; Lang, F.; Kim, D. W.; Cortes, J. E.; Hughes, T. P.; Hochhaus, A.; Minami, H.; Boquimpani, C.; Minami, Y.; DeAngelo, D. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia (BFORE Trial): 24-month efficacy update and results by 3-month BCR-ABL1 transcript levels
    Meeting Abstract

    Gambacorti-Passerini, C.; Brummendorf, T. H.; Abruzzese, E.; Rambaldi, A.; Ciceri, F.; Martino, B.; Hochhaus, A.; Deininger, M. W.; Mauro, M. J.; Chuah, C.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Long-term efficacy and cardiac, vascular and hypertension safety of bosutinib in previously treated patients with Philadelphia chromosome-positive leukemia
    Meeting Abstract

    Gambacorti-Passerini, C.; Brummendorf, T. H.; Kim, D. W.; Mauro, M. J.; Aguiar, J.; Viqueira, A.; Leip, E.; Cortes, J. E.
    Haematologica (2018)

    Fulltext@MSK | Save
  • Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms
    Journal Article

    Mughal, T. I.; Lion, T.; Abdel-Wahab, O.; Mesa, R.; Scherber, R. M.; Perrotti, D.; Mauro, M.; Verstovsek, S.; Saglio, G.; Van Etten, R. A.; more...
    Hematological Oncology (2018)

    Fulltext@MSK | Save
  • A novel germline variant in CSF3R reduces N-glycosylation and exerts potent oncogenic effects in leukemia
    Journal Article

    Spiciarich, D. R.; Oh, S. T.; Foley, A.; Hughes, S. B.; Mauro, M. J.; Abdel-Wahab, O.; Press, R. D.; Viner, R.; Thompson, S. L.; Chen, Q.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Treatment-free remission (TFR) in patients (pts) with chronic-phase chronic myeloid leukemia (CML-CP) and stable deep molecular response (DMR) discontinuing dasatinib (DASFREE)
    Meeting Abstract

    Saussele, S.; Shah, N.; García-Gutiérrez, J. V.; Jiménez-Velasco, A.; Larson, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casares, M. T.; Pane, F.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Long-term efficacy and cardiac, vascular and hypertension safety of bosutinib in previously treated patients with Philadelphia chromosome-positive leukemia
    Meeting Abstract

    Brümmendorf, T. H.; Gambacorti-Passerini, C.; Kim, D. W.; Mauro, M. J.; Aguiar, J.; Viqueira, A.; Leip, E.; Cortes, J. E.
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia (BFORE trial): 24-month efficacy update and results by 3-month BCR-ABL1 transcript levels
    Meeting Abstract

    Brümmendorf, T. H.; Hochhaus, A.; Isfort, S.; le Coutre, P.; Jentsch-Ullrich, K.; Schafhausen, P.; Gambacorti-Passerini, C.; Deininger, M. W.; Mauro, M. J.; Chuah, C.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save